Autoderm

Autoderm is an AI-powered dermatology API platform that provides medical-grade skin analysis for healthcare and digital health applications.

Reviewed by 7wData
Share Email

On this page

Profile

Provides an AI-powered dermatology API for medical-grade skin analysis in healthcare platforms.

Autoderm is an AI-powered dermatology API platform that provides medical-grade skin analysis for healthcare and digital health applications. Founded to address the growing demand for scalable dermatological triage, the company has developed a white-label solution that integrates with existing healthcare platforms. Autoderm's technology has achieved regulatory milestones, including CE-marked Class I medical device status, MHRA registration, and FDA Breakthrough Device Designation, positioning it as a credible player in clinical AI applications.

The platform is designed to assist healthcare providers, insurers, and digital health companies in streamlining patient triage and improving operational efficiency. While specific financials and customer metrics are not publicly disclosed, the regulatory approvals suggest traction in both European and U.S. markets. The company's focus on regulatory compliance and medical-grade accuracy differentiates it from consumer-facing skin analysis apps. Autoderm's recent FDA Breakthrough Device Designation indicates potential for accelerated adoption in the U.S. healthcare system, particularly for teledermatology and primary care applications where skin condition triage is critical.

Track Autoderm and 240+ vendors.

48k+ subscribers read the daily AI & data note. One email, both newsletters. Unsubscribe anytime.

Products by Autoderm

Who buys this

  • Healthcare providers needing scalable dermatological triage
  • Digital health platforms integrating skin analysis features
  • Health insurers implementing pre-authorization workflows
  • Telemedicine companies offering dermatology services
  • Pharmaceutical companies conducting dermatological research

Strengths and what to watch

Strengths

  • Regulatory approvals including CE-mark, MHRA registration, and FDA Breakthrough Device Designation
  • White-label API allows seamless integration into existing healthcare platforms
  • Medical-grade accuracy distinguishes it from consumer skin analysis apps

Watch for

  • Competition from larger healthcare AI platforms expanding into dermatology
  • Regulatory hurdles in additional markets beyond current EU and U.S. approvals
  • Dependence on healthcare provider adoption rates for AI diagnostic tools

Key Information

Frequently Asked Questions

What is Autoderm?

Autoderm provides a medical-grade AI dermatology API for skin analysis in healthcare platforms. Its white-label solution integrates with existing systems, offering scalable triage for providers, insurers, and digital health companies. The technology holds CE-marked Class I device status, MHRA registration, and FDA Breakthrough Device Designation.

Is Autoderm FDA-approved?

Autoderm has received FDA Breakthrough Device Designation, accelerating its U.S. regulatory pathway. While not yet fully FDA-approved, this status indicates potential for faster adoption in teledermatology and primary care. The system also holds CE-marked Class I medical device status and MHRA registration in Europe.

How does Autoderm's API integrate with healthcare systems?

Autoderm offers a white-label API designed for seamless integration into existing healthcare platforms. It serves providers, insurers, and digital health companies needing dermatological triage. The medical-grade solution differs from consumer apps through clinical validation and compliance with healthcare data standards.

What makes Autoderm different from consumer skin analysis apps?

Autoderm provides medical-grade accuracy with regulatory approvals including CE-marked Class I device status and FDA Breakthrough Designation. Unlike consumer apps, it's designed for clinical integration, supporting healthcare workflows like triage, telemedicine, and insurer pre-authorization with validated performance.

Who uses Autoderm's dermatology AI?

Primary users include healthcare providers needing scalable triage, digital health platforms adding skin analysis, insurers implementing pre-authorization, telemedicine services, and pharma researchers. The API serves clinical rather than consumer applications, focusing on integration with existing medical workflows.

What are Autoderm's regulatory milestones?

Autoderm has achieved CE-marked Class I medical device status, MHRA registration in the UK, and FDA Breakthrough Device Designation. These validate its medical-grade claims and support adoption in European and U.S. healthcare systems for dermatological assessment and triage applications.

Sources

  1. autoderm.ai — Company description and product offering
  2. ec.europa.eu — CE-marked Class I medical device status
  3. pard.mhra.gov.uk — MHRA registration
  4. www.bvp.com — Context on health AI adoption trends